New European privacy regulation: Assessing the impact for digital medicine innovations

Trix Mulder (First author), Raj Jagesar, Aline Klingenberg, Jeanne Mifsud Bonnici, Martien Kas

Research output: Contribution to journalArticleAcademicpeer-review

20 Downloads (Pure)


The use of smartphone based data streams in relation to mental health research is steadily gaining traction in the field [1]. This approach, also known as digital phenotyping, yields continuous behavioural data which shows promise in uncovering new perspectives on human behaviour [2]. However, calls have recently been addressing the need for increased awareness regarding the privacy of the participants [3]. These concerns coincide with the new European General Data Protection Regulation (GDPR) that came into effect 25 May 2018 [4]. In most cases, the GDPR will fundamentally impact how research should go about handling highly sensitive (medical) data, since the GDPR comes with some new responsibilities and obligations for both controllers1 and processors2. One of these obligations requires organisations to carry out a Data Protection Impact Assessment (DPIA). This article will assess the impact of such a DPIA on research in practice.
Original languageEnglish
Pages (from-to)57-58
Number of pages2
JournalEuropean Psychiatry
Publication statusPublished - Oct 2018
Externally publishedYes


  • privacy
  • data protection
  • ehealth


Dive into the research topics of 'New European privacy regulation: Assessing the impact for digital medicine innovations'. Together they form a unique fingerprint.

Cite this